Last mentioned: Mar 20, 2026
ASH Annual Meeting
Curis targets presentation of initial proof-of-concept data for the CLL study.
Torrid Store Closures
Target date for an additional 30 store closures by Torrid to reach savings goals.
Q4 Earnings Release
Curis, Torrid, Caleres, and Lands' End all report Q4 2025 results.
PIPE Financing
Curis secured initial $20.2M in PIPE proceeds to fund oncology pipeline development.
Erivedge Wind-down
Royalties from Erivedge began winding down, prompting the strategic sale to Oberland.
Curis (CRIS) has successfully pivoted to a clinical-stage oncology focus, securing a cash runway into 2027 through a strategic asset sale and PIPE financing. Meanwhile, broader retail earnings from Torrid and Caleres reveal significant margin pressures from tariffs, signaling a complex macro environment for healthcare supply chains.
This page surfaces every story mentioning Curis across our healthcare coverage. We track each entity's appearance over time so readers can trace how the narrative evolves — which developments are isolated incidents, which build into longer arcs, and which reframe how operators in the space think about the entity. Story selection uses the same multi-source verification gate applied across the rest of our coverage.
Read our editorial methodology for how we identify, deduplicate, and score entity references. Our glossary defines the technical terms used across stories on this page, and our trends index contextualizes individual developments against the longer-running healthcare beat. Cross-entity comparisons live on our compare view.
| What you see | What it tells you |
|---|---|
| Story count | Number of distinct stories where Curis was a primary or referenced actor. |
| Recency clustering | Whether mentions are concentrated in a recent window (a news cycle) or distributed (a sustained arc). |
| Sentiment distribution | Aggregate sentiment of the stories mentioning this entity, weighted by impact score. |
| Cross-niche links | When the same entity surfaces in our sibling networks, we link to those views to enrich context. |